Lhasa Limited shared knowledge shared progress



8 December 2021

2021 Sartans: New Mutagenic Impurities - Azido Impurities


Sartans New Mutagenic Impurities Azido Impurities 800px

Dr. Reddy’s and Sindusfarma held a joint webinar which discussed Sartans - a new class of mutagenic impurities discovered in drugs commonly used to treat hypertension, heart and kidney diseases.

This webinar consisted of 3 speakers:

  1. Dr. Rakeshwar Bandichhor, Ph.D., FRSC, CChem, VP e Head of Chemistry, API-PR & D, Dr. Reddy’s
  2. Fernanda Waechter, Principal Application Scientist, Lhasa Limited.
  3. Raphael Sanches Pereira, Manager of the Synthetic Medicines Quality Assessment, GQMED/GGMED ANVISA.

In this webinar, attendees learnt about:

  • Azido and nitrosamine impurities: Formation, similarities, differences and their carcinogenicity.
  • Workflow and risk assessment to tackle Azido impurities
  • ANVISA Positioning and updates on Azido impurities
  • Headline Event (shown first above featured)

  • Featured Event

Back to events

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.